Omnicell appoints Bobby Ghoshal to Board of Directors as independent director

OMNICELL, INC.

Board expanded from 9 to 10; Ghoshal elected Class II director, term expiring at 2024 Annual Meeting.
Ghoshal is President of SaaS at ResMed with 30+ years experience in finance, semiconductors, healthcare.
He will serve on Corporate Governance Committee; receives initial RSU award of $160k plus $7.5k for committee role.
Part of ongoing board refreshment; 9 of 10 directors now independent.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kaushik Ghoshal

Director

OMCL · OMNICELL, INC.

Effective: 2023-07-06
Filed: July 11, 2023, 7:59 PM ET

On July 6, 2023, the Board of Directors (the “Board”) of Omnicell, Inc. (the “Company”) increased the size of the Board from nine (9) to ten (10) members and elected Kaushik “Bobby” Ghoshal, effective immediately, to serve as a member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Kaushik Ghoshal was elected as Director at OMNICELL, INC..

Action: elected
Role: Director

Exact text from the filing

On July 6, 2023, the Board of Directors (the “Board”) of Omnicell, Inc. (the “Company”) increased the size of the Board from nine (9) to ten (10) members and elected Kaushik “Bobby” Ghoshal, effective immediately, to serve as a member of the Board.

View on SEC.gov

OMNICELL, INC. filing history →

Source: SEC EDGAR

accession 0000926326-23-000025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.